Tonix Pharmaceuticals (TNXP) Institutional Ownership $13.94 -0.32 (-2.25%) As of 01:02 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Tonix Pharmaceuticals (NASDAQ:TNXP)CurrentInstitutional OwnershipPercentage82.26%Number ofInstitutional Buyers(last 12 months)38TotalInstitutional Inflows(last 12 months)$28.14MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$631.72K Get TNXP Insider Trade Alerts Want to know when executives and insiders are buying or selling Tonix Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data TNXP Institutional Buying and Selling by Quarter Tonix Pharmaceuticals Major Shareholders & Ownership History ExportReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/19/2026Bank of America Corp DE60,958$838K0.0%+101.1%0.382% 5/5/2026 Bank of New York Mellon Corp30,426$418K0.0%+26.4%0.227% 4/23/2026 SJS Investment Consulting Inc.10,004$138K0.0%N/A0.075% 2/18/2026 Millennium Management LLC22,946$358K0.0%-56.5%0.189% 2/18/2026 Man Group plc18,442$288K0.0%N/A0.152% 2/18/2026 Engineers Gate Manager LP14,263$223K0.0%+63.7%0.117% 2/18/2026 Balyasny Asset Management L.P.185,352$2.90M0.0%N/A1.523% 2/17/2026 AQR Capital Management LLC20,020$313K0.0%N/A0.164% 2/17/2026 Price T Rowe Associates Inc. MD10,933$171K0.0%N/A0.090% 2/16/2026 Barclays PLC22,231$347K0.0%+78.3%0.183% Get the Latest News and Ratings for TNXP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tonix Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/13/2026 Charles Schwab Investment Management Inc.33,404$522K0.0%+24.7%0.274% 2/13/2026 State Street Corp191,855$3.00M0.0%+25.8%1.576% 2/13/2026 Wells Fargo & Company MN15,430$241K0.0%+114.6%0.127% 2/12/2026 Nuveen LLC93,402$1.46M0.0%+507.7%0.767% 2/11/2026 Los Angeles Capital Management LLC9,268$145K0.0%N/A0.076% 2/11/2026 State of Wyoming1,745$27K0.0%N/A0.014% 2/10/2026 Goldman Sachs Group Inc.26,808$419K0.0%+110.7%0.220% 2/9/2026 Geode Capital Management LLC271,904$4.25M0.0%+35.3%2.234% 2/6/2026 Leonteq Securities AG5,700$89K0.0%N/A0.047% 2/2/2026 Strs Ohio7,800$122K0.0%+9.9%0.064% 11/17/2025 Millennium Management LLC52,731$1.27M0.0%+494.0%0.602% 11/17/2025Bank of America Corp DE4,651$112K0.0%+32.7%0.053% 11/14/2025 Squarepoint Ops LLC31,633$764K0.0%N/A0.361% 11/13/2025 UBS Group AG51,581$1.25M0.0%+129.6%0.588% 11/13/2025 Capital Fund Management S.A.62,948$1.52M0.0%N/A0.718% 11/13/2025 Russell Investments Group Ltd.1,198$29K0.0%N/A0.014% 11/12/2025 Abacus Wealth Partners LLC15,000$362K0.1%N/A0.171% 11/7/2025Vanguard Group Inc.556,957$13.46M0.0%+238.1%6.354% 11/6/2025 Rhumbline Advisers12,206$295K0.0%+8.0%0.139% 10/30/2025 Strs Ohio7,100$172K0.0%+153.6%0.081% 10/23/2025 Nisa Investment Advisors LLC14,800$358K0.0%N/A0.169% 8/15/2025 Tower Research Capital LLC TRC 7,172$258K0.0%+108.4%0.082% 8/15/2025 BNP Paribas Financial Markets1,815$65K0.0%N/A0.021% 8/15/2025Bank of America Corp DE3,505$126K0.0%-39.1%0.040% 8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.4,143$149K0.0%N/A0.047% 8/13/2025 JT Stratford LLC6,441$232K0.0%N/A0.088% 8/13/2025 New York State Common Retirement Fund2,900$104K0.0%N/A0.039% 8/13/2025 State Board of Administration of Florida Retirement System6,916$249K0.0%N/A0.094% 8/12/2025 Ameritas Investment Partners Inc.773$28K0.0%N/A0.011% 8/12/2025 Rhumbline Advisers11,298$406K0.0%-17.4%0.154% I was right about SpaceX (Ad)Jeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,000%. Now he says SpaceX is shaping up to be the biggest IPO of the decade - and three key milestones just confirmed it. In the past 21 days: SpaceX crossed 10,000 active satellites, Elon filed confidential IPO paperwork with the SEC, and another rocket launched 25 more satellites. Two-thirds of every satellite in orbit now belongs to one company. The public filing could drop any day.See how to claim your stake in SpaceX before the public can8/12/2025 Legal & General Group Plc689$25K0.0%N/A0.009% 8/12/2025 JPMorgan Chase & Co.3,576$129K0.0%N/A0.049% 8/8/2025 Police & Firemen s Retirement System of New Jersey1,729$62K0.0%N/A0.024% 8/8/2025 Geode Capital Management LLC175,212$6.31M0.0%+182.4%2.382% 5/29/2025Rhumbline Advisers13,670$244K0.0%N/A0.187% 5/15/2025Royal Bank of Canada34,153$610K0.0%N/A0.531% 5/13/2025Caitong International Asset Management Co. Ltd22,662$405K0.3%N/A0.352% 5/12/2025Virtu Financial LLC16,878$302K0.0%-73.6%0.262% 5/5/2025IFP Advisors Inc10,000$179K0.0%N/A0.155% 4/8/2025Rhumbline Advisers13,670$244K0.0%N/A0.212% 2/17/2025Two Sigma Investments LP200,797$66K0.0%N/A10.738% 2/17/2025Point72 Asset Management L.P.1,596,344$526K0.0%N/A85.366% 2/17/2025Millennium Management LLC284,123$94K0.0%-21.4%15.194% 2/14/2025Jane Street Group LLC1,662,682$548K0.0%+5,932.3%88.961% 2/14/2025Northern Trust Corp489,735$162K0.0%N/A26.203% 2/12/2025Geode Capital Management LLC1,971,894$650K0.0%+1,600.1%105.449% 2/10/2025Commonwealth Equity Services LLC120,292$40K0.0%N/A6.433% 1/22/2025PFG Investments LLC218,003$72K0.0%N/A0.117% 8/6/2024Acadian Asset Management LLC57,762$39K0.0%-82.8%1.934% 5/10/2024Acadian Asset Management LLC335,373$61K0.0%+260.6%0.397% 2/13/2024Armistice Capital LLC3,770,000$1.52M0.0%+160.0%14.088% 11/15/2023Sabby Management LLC1,247,465$680K0.5%N/A7.024% 11/15/2023Armistice Capital LLC1,450,000$790K0.0%N/A8.164% 8/7/2023Acadian Asset Management LLC68,743$108K0.0%-57.1%0.639% 7/25/2023Raymond James & Associates44,364$70K0.0%-83.3%0.429% 5/1/2023Virtu Financial LLC58,883$35K0.0%-68.7%0.094% 4/14/2023Raymond James & Associates266,188$157K0.0%+58.4%0.425% 2/15/2023Tang Capital Management LLC4,500,419$1.75M0.3%N/A7.822% 11/7/2022Virtu Financial LLC129,891$69K0.0%N/A0.290% 5/11/2022GSA Capital Partners LLP1,887,989$435K0.1%+6.0%0.354% 5/10/2022Edmond DE Rothschild Holding S.A.300,000$69K0.0%+200.0%0.056% 2/14/2022Point72 Hong Kong Ltd348,383$125K0.0%+3,344.6%0.070% 2/14/2022GSA Capital Partners LLP1,781,617$637K0.1%+245.1%0.359% 2/11/2022Renaissance Technologies LLC10,699,831$3.83M0.0%+77.2%2.156% 2/8/2022ProShare Advisors LLC158,760$57K0.0%+243.6%0.032% 2/8/2022Northern Trust Corp3,839,725$1.38M0.0%+17.9%0.774% 2/7/2022SG Americas Securities LLC156,743$56K0.0%-31.7%0.032% TNXP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TNXP shares? During the previous two years, 49 institutional investors and hedge funds held shares of Tonix Pharmaceuticals. The most heavily invested institutionals were Vanguard Group Inc. ($13.46M), Geode Capital Management LLC ($4.25M), State Street Corp ($3.00M), Balyasny Asset Management L.P. ($2.90M), Capital Fund Management S.A. ($1.52M), Nuveen LLC ($1.46M), and UBS Group AG ($1.25M).Learn more on Tonix Pharmaceuticals' institutional investors. What percentage of Tonix Pharmaceuticals' stock is owned by institutional investors? 82.26% of Tonix Pharmaceuticals' stock is owned by institutional investors. Learn more on TNXP's institutional investor holdings. Which institutional investors have been buying Tonix Pharmaceuticals' stock? Of the 47 institutional investors that purchased Tonix Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Geode Capital Management LLC ($2.04M), Jane Street Group LLC ($1.64M), Point72 Asset Management L.P. ($1.60M), Northern Trust Corp ($489.74K), Vanguard Group Inc. ($392.23K), PFG Investments LLC ($218.00K), and Two Sigma Investments LP ($200.80K). How much institutional buying is happening at Tonix Pharmaceuticals? Institutional investors have bought a total of 1,288,428 shares in the last 24 months. This purchase volume represents approximately $28.14M in transactions. Which of Tonix Pharmaceuticals' major shareholders have been selling company stock? The following institutional investors have sold Tonix Pharmaceuticals stock in the last 24 months: Millennium Management LLC ($29.79K), Rhumbline Advisers ($2.37K), and Bank of America Corp DE ($2.26K). How much institutional selling is happening at Tonix Pharmaceuticals? Institutional investors have sold a total of 34,412 shares in the last 24 months. This volume of shares sold represents approximately $631.72K in transactions. Related Companies Gyre Therapeutics Major Shareholders Aerovate Therapeutics Major Shareholders Solid Biosciences Major Shareholders Sutro Biopharma Major Shareholders CryoPort Major Shareholders CytomX Therapeutics Major Shareholders Aclaris Therapeutics Major Shareholders Arvinas Major Shareholders Tilray Brands Major Shareholders Zevra Therapeutics Major Shareholders This page (NASDAQ:TNXP) was last updated on 5/19/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tonix Pharmaceuticals Holding Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tonix Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
